top of page

High Throughput Illucidx Covid-19 RT-LAMP

  • Utilizes Reverse Transcription (RT), Isothermal Loop-mediated Amplification (LAMP) Nucleic acid Test

  • Nasopharyngeal (NP) swabs compatible to determine the presence SARS-Cov-2 genetic material (RNA) in patients with signs of Covid-19 Symptoms. 

  • Clinically validated and pending regulatory review. 

  • Clinical validation data demonstrates that the level of detection using our primer sets approaches that of currently deployed qPCR based tests. 

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Please see the Instruction For Use (IFU) document for further details and validation data. This diagnostic has been clinically validated and independent review of this validation is pending. 

​

​

​

​

workflow of Illucidx COVID-19 RT-LAMP

TM​

Near-Patient Platform Illucidx Covid-19 Saliva LAMP

  • Utilizes Isothermal Loop-mediated Amplification (LAMP) Nucleic acid test and Visual Detection.

  • Point-of-care diagnostic platform utilizing off the shelf hardware.

  • Low cost, Rapid, Sensitive and Specific detection.

  • 15 min Extraction and 45 min Amplification.

  • Health Canada Interim Order Submission Pending. 

  • Can be performed in EMS and in remote locations 

​

​

​

​

​

​

​

​

​

​

Please see the Instruction For Use (IFU) document for further details and validation data.  

​

​

​

​

​

Flowthrough of COVID-19 Saliva LAMP

TM​

Coming Soon: Cartridge Based Diagnostic Testing

 
  • Simple point of care solution for results in less than an hour

  • Extremely portable

  • Increased Reproducibility

  • Minimal labour and infrastructure cost

  • Simple easy to use hardware

  • Decreased risk of contamination   

​

For support, more details, or requests please contact us now: 

​

​

​

​

LogoMakr-0D12bz-300dpi_edited.png

Headquartered in Calgary, Alberta, Canada we hope to enable broad access to ultra-sensitive diagnostics tools for settings across the globe. Our first priority is, and will always remain, to improve clinical outcomes.

Please email for direct number: 

illucidx@gmail.com

​

 

HSC B724A

3330 Hospital Dr NW

Calgary, AB, T2N 4N1

Canada

  • LinkedIn

© 2020 Illucidx Inc Previously Elucidx Inc.

bottom of page